Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Recruiting 387Active not recruiting 214Completed 145Terminated 76Not yet recruiting 73Suspended 10Withdrawn 9Enrolling by invitation 4Approved for marketing 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Dermatologic 1Breast 1

Conditions

Neoplasms 51Breast Neoplasms 40Colorectal Neoplasms 26Prostatic Neoplasms 22Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 15Stomach Neoplasms 14Hematologic Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Colonic Neoplasms 9Urinary Bladder Neoplasms 8Lymphoma, Follicular 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Ovarian Neoplasms 7Melanoma 7Liver Neoplasms 7Leukemia, Myeloid, Acute 7Disease 7Anxiety Disorders 7Myasthenia Gravis 6Multiple Myeloma 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Rectal Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma 5

Interventions

futibatinib 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Neoplasm Metastasis × 1 year × Clear all
NCT06506955 2026-05-28

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

Taiho Oncology, Inc.

Phase 2/3 Enrolling by invitation
15 enrolled
Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

NCT00068003 2026-05-01

Harvesting Cells for Experimental Cancer Treatments

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
7,000 enrolled
BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms

NCT06508138 2026-03-06

J21112LINKED

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Enrolling by invitation
24 enrolled

Neoplasm Metastasis, Recurrence

NCT07372261 2026-01-30

PORTENT

Casa Sollievo della Sofferenza IRCCS

Enrolling by invitation
1,000 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡